IONS vs PCB · rev $226.6M vs P/E 11, rev $2.8M
Ionis Pharmaceuticals Inc (IONS) versus PCB Bancorp (PCB) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
PCB Bancorp (PCB) is a banks - regional company listed on US.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported PCB revenue for 2024-12-31 was $2.8M. Net income was $25.8M. Revenue was up 4.7% from 2023-12-31 to 2024-12-31. PCB currently screens at market cap $308.8M and trailing P/E 10.8.
IONS currently screens at market cap $12.28B. PCB currently screens at market cap $308.8M and trailing P/E 10.8.
Not investment advice. Open the IONS and PCB stock pages for the full models.
Not investment advice.